| Cytokines | Assessment point | HIV-1 positive | HIV negative | Community controls | ||||
| Fe pos (Sgr I) n = 54 | Fe neg (Sgr II) n = 54 | Fe pos (Sgr III) | Fe neg (Sgr IV) | (Sgr V) | ||||
| Category of ARI on follow up | Category of ARI on follow up |
|
|
| ||||
| PT n = 38 | non-PT n = 16 | PT n = 10 | non-PT n = 44 | n = 30 | n = 50 | n = 40 | ||
| IL-1β (pg/ml) | En | 67 ± 18.6#§ | 19 ± 8.6 | 21 ± 11.4 | 19 ± 14.8 | 58 ± 22.6# | 14 ± 11.4 | 17 ± 12.2 |
| Fu | 102 ± 28.5* | 21 ± 10.5 | 26 ± 6.7 | 18 ± 8.6 | NA | NA | NA | |
| IL-6 (pg/ml) | En | 102 ± 32.4#§ | 47 ± 18.2 | 49 ± 24.2 | 39 ± 13.9 | 90 ± 31.4# | 40 ± 20.8 | 42 ± 22.6 |
| Fu | 145 ± 27.6* | 55.1 ± 22.7 | 45 ± 28.4 | 42 ± 17.6 | NA | NA | NA | |
| IL-8 (pg/ml) | En | 165 ± 40.4#§ | 92 ± 28.4 | 88 ± 28.8 | 81 ± 20.5 | 147 ± 32.2# | 73 ± 28.4 | 85 ± 32.4 |
| Fu | 263 ± 27.3* | 96 ± 32.5 | 100 ± 34.9 | 88 ± 27.4 | NA | NA | NA | |
| IL-12p70 (pg/ml) | En | 3.8 ± 3.5‽‡ | 8.4 ± 4.6‽ | 9.4 ± 4.6‽‡ | 16.6 ± 6.9‽ | 6.9 ± 3.2‽ | 32.4 ± 16.8 | 42.4 ± 18.6 |
| Fu | 12.4 ± 4.2* | 16.1 ± 5.6* | 20.4 ± 4.9* | 24.8 ± 5.7* | NA | NA | NA | |